about
Innovative Approaches to Improve Anti-Infective Vaccine Efficacy.NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.Development and validation of an NMR-based identity assay for bacterial polysaccharides.Strategy for streamlined release identity testing of chromatography media.Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection.Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus.NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.Questionnaire for a biotech: NovaDigm Therapeutics.A robust approach for the quantitation of viral concentration in an adenoviral vector-based human immunodeficiency virus vaccine by real-time quantitative polymerase chain reaction.A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine (RotaTeq).Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis.Evaluation of the purity of a purified, inactivated hepatitis A vaccine (VAQTA)Characterization and quantification of C-polysaccharide in Streptococcus pneumoniae capsular polysaccharide preparationsQuantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type b polysaccharide intermediate for PedvaxHIBAn optimized procedure for sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of hydrophobic peptides from an integral membrane protein
P50
Q30397141-BC1EA948-A65B-4B44-B739-E23CB9682E6DQ30528889-29C63CF3-4CDE-4C68-91A0-600636FD02FBQ31562220-2F856D62-53C5-4ECD-B021-DCAD2642B014Q33208367-C08F99AF-5619-480C-9CA5-33F0A2595AF1Q34250054-DDE172DE-5402-4CB3-8DDB-59E7573688B1Q34792962-F2FF366F-568E-414C-96EC-68D50E5C0789Q36138054-C26B1055-B4D0-4668-9F65-D6E117CCE298Q37399422-D737A18F-074D-451E-8AC1-1AA4CAF87F68Q42724923-62B212B6-CB0A-4A73-8D11-9752ED664DE1Q44443614-F209AE50-104C-4F21-BF09-95A05137A775Q52561594-6B38D481-ED05-4461-8AD6-E299F62FEFA6Q54637338-16539174-46B1-4653-A688-CD8C6C3662C6Q55396489-5CE6CEA0-D577-430F-8919-CBC7962F14BFQ78100563-7A99E618-1A3D-428C-A9B2-DEAF670707C2Q81202378-166BAD6D-2AEF-4BB6-B63D-FAA2102D3D3AQ81362054-309F6B9F-9810-461C-B652-FC23B1C11863Q93513268-91971602-0E2E-4D7E-926A-F43A16B5818B
P50
description
researcher
@en
name
Hennessey JP Jr
@en
Hennessey JP Jr
@nl
type
label
Hennessey JP Jr
@en
Hennessey JP Jr
@nl
prefLabel
Hennessey JP Jr
@en
Hennessey JP Jr
@nl
P106
P31
P496
0000-0003-2252-0421